Gandjbakhch I, Rottembourg J, Conseiller C, Mattei M F, Christides C, Guiraudon G, Cabrol C, Cabrol A
Nouv Presse Med. 1975 Mar 22;4(12):867-70.
The favourable clinical results of cardiac transplantation merit wider application of this therapeutic measure in the management of non-obstructive primary cardiomyopathies and diffuse myocardial fibrosis secondary to coronary artery disease and in its terminal phase, in the absence of any absolute contraindication (pulmonary resistance too high, diabetes, gastrointestinal disorder, infection, patient too old.). Close cooperation between departments of cardiology and surgical transplantation centres, with systematic study of the patients pre-operatively and the setting up of a waiting list of recipients, will make possible in the future the improvement of the already encouraging results of cardiac transplantation.
心脏移植良好的临床效果值得在治疗非梗阻性原发性心肌病、冠状动脉疾病继发的弥漫性心肌纤维化及其终末期时更广泛地应用这一治疗措施，前提是不存在任何绝对禁忌证（肺阻力过高、糖尿病、胃肠道疾病、感染、患者年龄过大等）。心脏病学部门与外科移植中心密切合作，对患者进行系统的术前研究并建立受者等待名单，未来将有可能进一步改善心脏移植本已令人鼓舞的结果。
